Human immunodeficiency virus type 1 clade B and C gp120 differentially induce neurotoxin arachidonic acid in human astrocytes: Implications for neuroAIDS

Journal of NeuroVirology

Volumn 17, Issue 3, 2011, Pages 230-238

  Samikkannu, Thangavel ^a   Agudelo, Marisela ^a   Gandhi, Nimisha ^a   Reddy, Pichili V B ^a   Saiyed, Zainulabedin M ^a   Nwankwo, Donald ^a   Nair, Madhavan P N ^a  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

COX 2; HIV 1 gp120; NMDA receptor; PGE 2; TBXA 2 R

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 2; GLUTAMINE; GLYCOPROTEIN GP 120; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROSTAGLANDIN E2; THROMBOXANE A2 RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; ASTROCYTE; CLADISTICS; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION;

AIDS DEMENTIA COMPLEX; ARACHIDONIC ACID; ASTROCYTES; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CYCLOOXYGENASE 2; DINOPROSTONE; DOWN-REGULATION; GLUTAMINE; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; NEUROTOXINS; PROTEIN ISOFORMS; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79959980496     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-011-0026-5     Document Type: Article

References (52)

1. Brenneman DE, McCune SK, Mervis RF, Hill JM (1994) gp120 as an etiologic agent for neuroAIDS: neurotoxicity and model systems. Adv Neuroimmunol 4:157-165 (Pubitemid 24325859)
2. Brooke S, Chan R, Howard S, Sapolsky R (1997) Endocrine modulation of the neurotoxicity of gp120: implications for AIDS related dementia complex. Proc Natl Acad Sci USA 94:9457-9462 (Pubitemid 27357851)
3. Chang J, Jozwiak R, Wang B, Ng T, Ge YC, Bolton W, Dwyer DE, Randle C, Osborn R, Cunningham AL, Saksena NK (1998) Unique HIV type 1 V3 region sequences derived from six different regions of brain: region-specific evolution within hostdetermined quasispecies. AIDS Res Hum Retroviruses 14:25-30 (Pubitemid 28028613)
4. Choe H, Martin KA, Farzan M, Sodroski J, Gerard NP, Gerard C (1998) Structural interactions between chemokine receptors, gp120 Env and CD4. Semin Immunol 10:249-257 (Pubitemid 28347041)
5. Corasaniti MT, Melino G, Navarra M, Garaci E, Finazzi-Agro A, Nistico G (1995) Death of cultured neuroblastoma cells induced by HIV-1 gp120 is prevented by NMDA receptor antagonists and inhibitors of nitric oxide and cyclooxygenase. Neurodegeneration 4:315-321
6. Corasaniti MT, Navarra M, Catani MV, Melino G, Nistico G, Finazzi-Agro A (1996) NMDA and HIV-1 coat protein, GP120, produce necrotic but not apoptotic cell death in human CHP100 neuroblastoma cultures via a mechanism involving calpain. Biochem Biophys Res Commun 229:299-304 (Pubitemid 27013747)
7. Corasaniti MT, Navarra M, Nistico S, Rotiroti D, Maccarrone M, Melino G, Finazzi Agro A (1998) Requirement for membrane lipid peroxidation in HIV-1 gp120-induced neuroblastoma cell death. Biochem Biophys Res Commun 246:686-689 (Pubitemid 28420919)
8. Corasaniti MT, Strongoli MC, Piccirilli S, Nistico R, Costa A, Bilotta A, Turano P, Finazzi-Agro A, Bagetta (2000) Apoptosis induced by gp120 in the neocortex of rat involves enhanced expression of cyclooxygenase type 2 (COX-2) and is prevented by NMDA receptor antagonists and by the 21-aminosteroid U-74389G. Biochem Biophys Res Commun 274:664-669 (Pubitemid 30663677)
9. Corasaniti MT, Bellizzib C, Russo R, Colica C, Amantea D, Di Renzo G (2003) Caspase-1 inhibitors abolish deleterious enhancement of COX-2 expression induced by HIV-1 gp120 in human neuroblastoma cells. Toxicol Lett 139:213-219 (Pubitemid 36298980)
10. Dawson VL, Dawson TM, Uhl GR, Synder SH (1993) Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc Natl Acad Sci USA 90:3256-3259 (Pubitemid 23111344)
11. Dreyer EB, Lipton SA (1995) The coat protein gp120 of HIV-1 inhibits astrocyte uptake of exciTatory amino acids via macrophage arachidonic acid. Eur J Neurosci 7:2502-2507
12. Dreyer EB, Kaiserr PK, Offermann JT, Lipton SA (1990) HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 248:364-367
13. Ensoli B, Buonaguro L, Barillari G, Fiorelli V, Gendelman R, Morgan RA, Wingfield P, Gallo RC (1993) Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol 67:277-287 (Pubitemid 23002988)
14. Galicia O, Sanchez-Alavez M, Mendez Diaz M, Navarro L, Prospero-Garcia O (2002) HIV glycoprotein 120: possible etiological agent of AIDS-associated dementia. Rev Invest Clin 54:437-452 (Pubitemid 36104443)
15. Gandhi N, Saiyed Z, Samikkannu T, Rodriguez JW, Rao KVK, Nair MN (2009) Differential effects of HIV-1 clade B and clade C Tat protein on expression of proand anti-inflammatory cytokines by primary monocytes. AIDS Res Hum Retroviruses 25:691-699
16. Gendelman HE, Genis P, Jett M, Zhai QH, Nottet HS (1994) An experimental model system for HIV-1-induced brain injury. Adv Neuroimmunol 4:189-193 (Pubitemid 24325863)
17. Genis P, Jett M, Bernton EW, Boyle T, Gelbard HA, Dzenko K, Keane RW, Resnick L, Mizrachi Y, Volsky DJ et al (1992) Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med 176:1703-1718
18. Gnanakaran S, Lang D, Daniels M, Bhattacharya T, Derdeyn CA, Korber B (2007) Clade-specific differences between human immunodeficiency virus type 1 clades B and C: diversity and correlations in C3-V4 regions of gp120. J Virol 81:4886-4891 (Pubitemid 46668687)
19. Gonzalez-Scarano F, Baltuch G (1999) Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 22:219-240 (Pubitemid 29144887)
20. Grant I, Sacktor H, McArthur J (2005) HIV neurocognitive disorders. In: Gendelman HE, Grant I, Everall I, Lipton SA, Swindells S (eds) The neurology of AIDS, 2nd edn. Oxford University Press, London, UK, pp 357-373
21. Gray F, Adle-Biassette H, Chrétien F, Lorin de la Grandmaison G, Force G, Keohane C (2001) Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments. Clin Neuropathol 20:146-155
22. Griffin DE, Wesselingh SL, McArthur JC (1994) Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia. Ann Neurol 35:592-597
23. 2+ responses to HIV-1 gp120 in cultured human fetal brain cells. Neuroscience 91:1369-1378
24. Kaleebu P, Ross A, Morgan D, Yirrell D, Oram J, Rutebemberwa A, Lyagoba F, Hamilton L, Biryahwaho B, Whitworth J (2001) Relationship between HIV-1 Env subtypes A and D and disease progression in a rural Ugandan cohort. AIDS 15:293-299 (Pubitemid 32163814)
25. Kaul M, Lipton SA (1999) Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc Natl Acad Sci USA 96:8212-8216 (Pubitemid 29328434)
26. Li W, Huang Y, Reid R, Steiner J, Malpica-Llanos T, Darden TA, Shankar SK, Mahadevan A, Satishchandra P, Nath A (2008) NMDA receptor activation by HIV-Tat protein is clade dependent. J Neurosci 28:12190-12198
27. Lipton SA, Sucher NJ, Kaiser PK, Dreyer EB (1991) Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron 7:111-118
28. Maccarrone M, Navarra M, Corasaniti MT, Nisticò G, Finazzi Agrò A (1998) Cytotoxic effect of HIV-1 coat glycoprotein gp120 on human neuroblastoma CHP100 cells involves activation of the arachidonate cascade. Biochem J 333:45-49 (Pubitemid 28342490)
29. Mattson MP, Haughey NJ, Nath A (2005) Cell death in HIV dementia. Cell Death Differ 12:893-904 (Pubitemid 41030604)
30. Meucci O, Miller RJ (1996) gp120-induced neurotoxicity in hippocampal pyramidal neuron cultures: protective action of TGF-beta1. J Neurosci 335:639-642
31. Mishra M, Vetrivel S, Siddappa NB, Ranga U, Seth P (2008) Cladespecific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons: significance of dicysteine C30C31 motif. Ann Neurol 63:366-376 (Pubitemid 351499866)
32. Muller WEG, Schroder HC, Ushijima H, Dapper J, Bormann J (1992) gp120 of HIV-1 induces apoptosis in rat cortical cell cultures: prevention by memantine. Eur J Pharmacol 226:209-214
33. Nath A (2002) Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J Infect Dis 186(Suppl 2):S193-S198 (Pubitemid 35370481)
34. Nottet SLM, Jett M, Flanagan CR, Zhai QH, Persidsky Y, Rizzino A, Bernton EW, Genis P, Baldwin T, Schwartz J (1996) A regulatory role for astrocytes in HIV-1 encephalitis: an overexpression of eicosanoids, platelet-activating factor, and tumor necrosis factorby activated HIV-1-infected monocytes is attenuated by primary human astrocytes. J Immunol 154:3567-3581
35. Pattarini R, Pittaluga A, Raiteri M (1998) The human immunodeficiency virus-1 envelope protein gp120 binds through its V3 sequence to the glycine site of N-methyl-D-aspartate receptors mediating noradrenaline release in the hippocampus. Neuroscience 87:147-157 (Pubitemid 28351175)
36. Raber J, Toggas SM, Lee S, Bloom FE, Epstein CJ, Mucke L (1996) Central nervous system expression of HIV-1 gp120 activates the hypothalamic-pituitary- adrenal axis: evidence for involvement of the NMDA receptors and nitric oxide synthase. Virology 226:362-373 (Pubitemid 27025816)
37. Rizzuto CD, Wyatt R, Hernandez-Ramos N, Sun Y, Kwong PD, Hendrickson WA, Sodroski J (1998) A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 280:1949-1953 (Pubitemid 28299405)
38. Robertson D, Anderson J, Bradac J, Carr J, Foley B, Funkhouser R, Gao F, Hahn B, Kalish, M, Kuiken C, Learn G, Leitner T, McCutchan F, Osmanov S, Peeters M, Pieniazek D, Salminen OM, Sharp P, Wolinsky SM, Korber B (2001) A reference guide to HIV-1 classification. Los Alamos National Laboratory, Los Alamos, New Mexico
39. Samikkannu T, Saiyed Z, Rao KVK, Dakshayani KB, Rodriguez JW, Papuashvili MN, Nair MP (2009) Differential regulation of indoleamine-2, 3-dioxygenase (IDO) by HIV-1 clade B and C Tat proteins. AIDS Res Hum Retroviruses 25:329-335
40. Samikkannu T, Rao KV, Gandhi N, Saxena SK, Nair MP (2010) Human immunodeficiency virus type 1 clade B and C Tat differentially induce indoleamine 2, 3-dioxygenase and serotonin in immature dendritic cells: Implications for neuroAIDS. J Neurovirol 16:255-263
41. Sardar AM, Reynolds GP (1995) Frontal cortex indoleamine-2, 3-dioxygenase activity is increased in HIV-1-associated dementia. Neurosci Lett 187:9-12
42. Satishchandra P, Nalini A, Gourie-Devi M, Khanna N, Santosh V, Ravi V, Desai A, Chandramuki A, Jayakumar PN, Shankar SK (2000) Profile of neurologic disorders associated with HIV/AIDS from Bangalore, South India (1989-96). Indian J Med Res 111:14-23 (Pubitemid 30213883)
43. Scorziello A, Floriao T, Bajetto A, Schettini G (1998) Intracellular signaling mediating HIV-1 gp120 neurotoxicity. Cell Signal 10:75-84 (Pubitemid 28026597)
44. Sei S, Saito K, Stewart SK, Crowley JS, Brouwers P, Kleiner DE, Katz DA, Pizzo PA, Heyes MP (1995) Increased human immunodeficiency virus (HIV) type 1 DNA content and quinolinic acid concentration in brain tissues from patients with HIV encephalopathy. J Infect Dis 172:638-647
45. Shankar AV, Sastry J, Erande A (2005) Making the choice: the translation of global HIV and infant feeding policy to local practice among mothers in Pune, India. J Nutr 135:960-965 (Pubitemid 40464140)
46. Shively CA, Mirkes SJ, Lu NZ, Henderson JA, Bethea CL (2003) Soy and social stress affect serotonin neurotransmission in primates. Pharmacogenomics J 3:114-121 (Pubitemid 36675712)
47. Souba WW (1992) In: Landes RG (ed) Glutamine-physiology, biochemistry, and nutrition in critical illness. R. G. Landes Co, Austin, TX, p 5
48. Tapia-Arancibia L, Rage F, Récasens M, Pin JP (1992) NMDA receptor activation stimulates phospholipase A2 and somatostatin release from rat cortical neurons in primary cultures. Eur J Pharmacol 225:253-262
49. Ushijima H, Nishio O, Klöcking R, Perovic S, Müller WEG (1995) Exposure to gp120 of HIV-1 induces an increased release of arachidonic acid in rat primary neuronal cell culture followed by NMDA receptor-mediated neurotoxicity. Eur J Neurosci 7:1353-1359
50. Vesce S, Bezzi P, Rossi D, Meldolesi J, Volterra A (1997) HIV-1 gp120 glycoprotein affects the astrocyte control of extracellular glutamate by both inhibiting the uptake and stimulating the release of the amino acid. FEBS Lett 411:107-109 (Pubitemid 27298381)
51. Wadia RS, Pujari SN, Kothari S (2001) Neurological manifestations of HIV disease. J Assoc Physicians India 49:343-348
52. Zhang K, Hawken M, Rana F, Welte FJ, Gartner S, Goldsmith MA, Power C (2001) Human immunodeficiency virus type 1 clade A and D neurotropism: molecular evolution, recombination, and coreceptor use. Virology 283:19-30 (Pubitemid 32911505)